Holly LaDuca

12PUBLICATIONS
80CO-AUTHORS
Cancer geneticsMedical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 12, 2022
Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment.

Matthew B Yurgelun, Hajime Uno, C Sloane Furniss

|May 23, 2022
Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.

Carolyn Horton, Kirsten Blanco, Min-Tzu Lo

|Jan 07, 2022
Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer Phenotypes.

Junne Kamihara, Carrie Horton, Yuan Tian

|Oct 30, 2021
Classification of the canonical splice alteration MUTYH c.934-2A > G is likely benign based on RNA and clinical data.

Felicia Hernandez, Blair R Conner, Marcy E Richardson

|Oct 21, 2021
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.

Siddhartha Yadav, Chunling Hu, Katherine L Nathanson

Pageof 2